RE:RE:RE:Cresendo Communication served V.IPA well for their US gambitAccountprince wrote: Crescendo was appointed a while back - not sure why they are now announcing again. The share price went to lofty heights in February when it was announced Dr Kellum was coming on board. With him joining this week and today's re-release of the Crescendo appointment we touched $0.60 per share. A stunning 20% drop in price so far.
It's not business fundamentals as nothing has been announced. So either the market views Dr Kellum joining along with Crescendo appointment negatively (why?) or there is manipulation of the share price as has been suggested for some time now (again why?). Logic dictates one or the other.
Hey AP
Not sure that Crescendo was ever previously announced. It was sussed out by some observant posters here (teh US IR firm's name mysteriously and suddenly appeared at the bottom of another unrelated release, hence the "Where's Walden" quips). Not sure why the delay.
As to your either/or proposition. The first is unlikely. The second may have some validity.
But I prefer a third possibility.
And that is that the market for undervalued, under-promoted Cdn stocks is highly inefficient. Daily movements cannot be easily explained by news releases. The only thing that make markets more efficient, and that can result in better or true value discovery is (1) more effective marketing and (2) more volume (preferably brought about by US dissemination and therefor higher demand).
Of course, low volume, off the radar stocks are subject to more manipulation at the hands of various (nefarious?) groups...whose interests vary over time.
Marketing, volume and being on the best exchange (ideally one that best matches the ultimate target market of the company) is the best solution to that problem.
IMHO
MM